The FDA should develop a new regulatory
framework to replace the 510(k) clearance process for moderate-risk medical
devices, advises a report issued July 29 by the Institute of Medicine.
In a recent editorial, I decried the unsafe conditions at some Chinese assembly plants. I had thought everyone could get behind such a stand, but I was wrong.